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Abstract
Background—Depression is becoming an increasing concern in cancer patients because of its
impact on quality of life. Although risk factors of having depression have been examined in the
literature, there has been no research examining these factors in older African American cancer
patients.
Objective—This study explores the demographic and illness-related risk factors in older African
American cancer patients.
Methods—Two hundred eighty-three patients were recruited from outpatient oncology clinics.
These older African American patients completed a questionnaire that included the Geriatric
Depression Scale as well as sociodemographic characteristics and medical information. χ2 Tests,
trend tests, and logistic regression were used to identify the demographic and illness-related factors
that predict depression in the sample.
Results—The overall prevalence of depression in the sample was 27.2%. Younger age (<65 years),
employment status, proximity to family, and multiple symptoms due to cancer or treatment were
independent predictors of depression.
Conclusion—This study represents the first attempt to describe the risk factors of depression within
older African American cancer patients. Findings indicate a high prevalence of depression in African
American cancer patients which can be attributed to identifiable risk factors.
Implications for Practice—An understanding of the risk factors associated with depression can
be used to identify those cancer patients at risk for depression and initiate early interventions to
improve psychological outcomes and lessen the potential burden of cancer on these patients.
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Depression affects approximately 15% to 25% of all cancer patients.1,2 However, because of
methodological issues and the difficulties in distinguishing symptoms of depression from
cancer, the actual prevalence of depression in cancer patients may be much greater.3 Although
the causal relationship between cancer and depression is not clear, an association has been
frequently cited.4 Depressive symptoms have been found in cancer patients experiencing
treatment adverse effects such as pain, sleep disturbances, and fatigue.5 Moreover, these
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adverse effects of cancer combined with depression lead to an overall reduction in health-
related quality of life.6 Depression in cancer patients is associated not only with poorer quality
of life and physical functioning but also with poorer survival rates.4,6–9
When cancer patients experience depressive symptoms at the time of diagnosis, there is an
increased likelihood of poor health outcomes. Depressive symptoms can also negatively impact
the pathology of the cancer and treatment compliance, leading to ineffective treatment and
higher risk of mortality.3 The research endeavors on cancer patients have recently shifted focus
to the psychological distress experienced by these individuals because it has become
increasingly apparent that a diagnosis of cancer also leads to depression and other mental
illnesses.10 Moreover, the possibility exists for cancer patients to develop psychological
distress such as anxiety and depression well beyond the completion of treatment.9,11
We used the psychosocial theory of late-life depression as the theoretical framework for this
study to examine the impact of social and economic factors on depression.12 According to this
model, 6 levels of physical, psychological, social, and environmental factors serve as the
precursors for late-life depression.12 These levels are (1) demographics (age, sex), (2) early
life events/achievements (eg, education), (3) later life events/achievements (eg, income,
marital status), (4) social integration (eg, community participation), (5) risk and protective
factors (eg, social support), and (6) provoking agents and coping efforts (eg, life stress and
coping).12 Based on this model, we conceptualize demographic and life achievement
characteristics as age, sex, education, marital status, employment status, income, insurance
status, and living alone. Life stress was characterized as illness-related characteristics such as
type of cancer, time since diagnosis, diagnosis stage, tumor stage, and presence of symptoms.
These risk factors provide an overall view for depression in older African American cancer
patients.
Studies have found several correlates of depression in cancer patients. Demographic
characteristics such as age, sex, marital status, proximity to family, education, and employment
status were associated with depression.13 Among cancer patients, it has been repeatedly shown
that younger adults and females experience more depression.14–20 Unmarried cancer patients
and patients who live alone have a greater risk of depression, which is likely the result of limited
social support.15,16,21 Education levels also make a difference as studies have shown that
cancer patients with a college degree are less likely to be depressed, and losing one’s job after
a cancer diagnosis leads to a greater risk of depression.15,22
Illness-related characteristics such as preexisting comorbidities, cancer stage, and effects of
cancer treatment were also correlated with depression.13 A high number of comorbidities can
predispose the cancer patients to depression.13,15,19 The stage at which cancer is diagnosed
also impacts psychological distress in cancer patients. A diagnosis at an advanced stage of
cancer with multiple symptoms due to the cancer or associated treatment also predisposes
patients to depression.14,23 As shown in these studies, there are many factors that can increase
the risk of depression in cancer patients.
Studies that have determined the risk factors of depression in patients with various demographic
and illness-related characteristics are generally limited to white samples. In a review of the
literature, only 2 studies explicitly examined race as a predictor of depression. These studies
concluded that African Americans have greater risk of depression within the cancer population.
19,24 The sheer lack of information on this under-served population is likely a contributing
factor to the existing disparities in mental healthcare and comorbidities related to cancer.
Because the information available on depression is tenuous among African American cancer
patients, it is important to identify common characteristics that may predispose these
individuals to experience depression. Our study will describe the demographic and illness-
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related characteristics of older African American cancer patients with depressive symptoms.
By assessing the characteristics of those individuals, better informed interventions aimed at




The findings reported in this article were derived from 283 older African American cancer
survivors recruited from outpatient oncology clinics in the southeastern United States. The
participants in this study were part of a larger National Institutes of Health–funded study,
Helping Older African American Cancer Survivors Cope Study (J.B.H., principal investigator).
The parent study was designed to evaluate a new measure of preferred coping strategies for
older African American cancer survivors.25 Participants completed a series of demographic
medical information, coping and quality-of-life measures, and the Geriatric Depression Scale–
Short Form (GDS-SF15) in a 1-time interview that lasted 45 minutes to an hour. Questionnaires
were administered in a face-to-face interview format by research staff, either in a private
consultation room while the patient was waiting for a health-related appointment or, if
participants preferred, in their home. Institutional review board approval for this study was
obtained from the University of North Carolina at Chapel Hill and Emory University.
Participants were eligible if they had a diagnosis of cancer, self-reported to be African
American, were without severe cognitive impairment, and were 50 to 89 years of age. Written
informed consent for interviews was obtained after participants were screened for severe
cognitive impairment with the Short-Form Mini-Mental State Examination.26 All participants
were found to be alert and oriented to time, person, and place.
Instruments
The factors likely to affect depression and examined in this report are categorized as
demographic and illness-related factors. Demographic factors consist of characteristics of the
person that may directly affect depression and include subject’s age, sex, yearly income,
education, marital status, proximity to family (living alone), employment status, and health
insurance status. Illness-related factors are those variables that characterize the life stress
situation such as length of time since diagnosis, existing comorbidities, and phase of illness.
13,14,19,21 For phase of illness, information on stage of cancer and treatment will be used to
determine illness phase. There are 4 phases of illness: phase 1—newly diagnosed persons,
phase 2—persons in first remission, phase 3—persons following the development of a second
primary lesion without metastasis, and phase 4—persons with metastatic disease.27 Phase of
illness has been used in research with cancer patients because it has been a strong predictor of
survival.27 Length of time since diagnosis was calculated based on the date of diagnosis and
the date of the interview.
The GDS-SF15 is a 15-item scale designed to screen for depression with elderly, medically ill
populations.28 The scale consists of 15 yes/no questions, and a score greater than 5 indicates
the possibility of depression. A score of 5 or higher has 60% sensitivity and 89% specificity
for a depression diagnosis.29 In a sample of geriatric outpatients, internal consistency reliability
was.86, and construct validity was supported through correlations with demographic and
personality variables.30 In this study, internal consistency (Cronbach α) reliability was.79.
Data Analysis
All analyses were performed in SAS, release 9.2. Analyses of the data included univariate
statistics to calculate the prevalence of depression among the total sample and demographic
factors. To assess the association of demographic and illness-related variables with possible
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depression, the Pearson χ2 test and the Cochran-Armitage test were used. The Cochran-
Armitage test was used to measure the underlying trend among variables with more than 2
ordered groups. This test has been frequently used to measure linear trend in clinical studies
in which there are different levels of exposure for a binary outcome. Then, to assess the
magnitude of the association of variables, logistic regression analyses were performed. Crude
and adjusted odds ratios and 95% confidence intervals were obtained. The confidence intervals
indicate significant findings when 1.00 is not in the range.
Results
Study Population
A total of 283 African American cancer patients completed the GDS-SF15 scale. The
demographic characteristics of the participants are shown in Table 1. The ages of the
participants in this study ranged from 50 to 87 years (mean, 63.5 [SD, 7.9] years). Participants
were diverse with women (n = 169, 59.7%) and men (n = 114, 40.3%). There were 162 high
school graduates (57.2%), and 121 of those that did not complete high school (42.8%). The
insured (n = 201, 71.0%) and the uninsured (n = 82, 29.0%) were also included in this study.
Nearly half of the women and men in this study (45.6%) lost or quit their jobs because of health
concerns or were retired (34.3%) at the time of the study interview. More than half of the
participants (59.7%) made less than $10,000 yearly, whereas 12.2% made more than $20,000.
Breast cancer (29.7%) was the most common cancer in the study sample, followed by lung
cancer (21.6%) and colon cancer (12.4%). Cancer was diagnosed in most participants (77.2%)
within the last 3 years.
Prevalence of Depressive Symptoms
The mean score for the GDS-SF15 was 3.23 (SD, 2.82). Using the recommended cutoff score
of 5 or higher as indicative of depression, these data showed that of 283 participants, 77 (27.2%)
were possibly depressed. The prevalence of GDS-SF15 scores of less than 5 was slightly higher
for women (27.8%) than for men (26.3%).
Demographic and Illness-Related Characteristics of African American Cancer Patients
We compared the distribution of demographic and illness-related factors between subgroups
within the sample of those African American cancer patients who were potentially depressed
and not depressed using χ2 and trend tests (Table 1). A power analysis showed that the sample
size gives adequate power for comparison of the possibly depressed to the “not depressed”
participants. Specifically, it yields 85% power to detect an effect size of 0.4 when comparing
the groups with respect to a factor with 2 levels.
Among the demographic characteristics, there was a significant relationship between age and
depression in that younger participants (<65 years) were more likely to be depressed than were
older participants (P <.0001). Lack of employment was also associated with depression (P <.
01). Participants who stated that they quit their jobs because of their poor health were more
likely to have high GDS-SF15 scores. People who did not have insurance and/or lived alone
were also more likely to be depressed (P = .02). Among illness-related characteristics, having
symptoms in relation to the cancer disease or the treatment was the only factor that had an
association with depression (P <.0001). Time since diagnosis of cancer, type of cancer, tumor
stage, and stage of cancer at diagnosis did not have a significant effect on depression among
those participants who scored within the range of being potentially depressed on the GDS-
SF15.
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Risk Factors of Having Depressive Symptoms
To better understand the magnitude of the associations between the demographic and illness-
related factors and depressive symptoms, we computed odds ratios for all variables
significantly (P <.05) related to depression (Table 2). In addition to computing crude odds
ratios for the variables, we fit a multivariate logistic regression model for depression containing
all factors significantly related to depression. The logistic regression model allows the
estimation of adjusted odds ratios, which summarize each variable’s relationship with
depression controlling for all other variables.
Even when controlling for age, employment status, insurance status, living alone, and presence
of symptoms (Table 2), participants in their 50s had nearly 3 times the odds of possible
depression as those who were 65 years or older. Participants who lived alone had 2.2 times the
odds of possible depression as those who did not. The presence of symptoms increased the
odds of possible depression by a factor of 2.7. Employment was still a factor after adjusting
for other variables, as those who lost their jobs because of health had odds of possible
depression that was 3.3 times that of participants who were employed. Controlling for all the
other factors in Table 2, the association between insurance status and depression was no longer
significant.
Discussion
In this report, the prevalence of depression using the GDS-SF15, a commonly used depression
survey, was consistent with reports from some cancer patients but higher than that of others.
The number (n = 77, 27.2%) of individuals with GDS-SF15 scores above the cutoff of 5,
indicative of depression, also exceeded that in research with other cancer populations.31–33
Other studies found prevalence rates in cancer patients ranging from 18% to 24%.32–34
However, the participants in these studies were primarily older (>65 years) white sample with
late-stage or advanced cancer. What is known about depression in African Americans comes
from studies examining mental health issues among community-dwelling populations and
populations with other chronic illnesses. Within the general African American population,
there is a similar lack of literature examining depression using the GDS-SF15 survey. Studies
have reported that, in general, African Americans tend to have a lower prevalence rate of
depression than other racial groups in the United States.35,36 However, depression is frequently
misdiagnosed in African Americans, a result of the stigma attached to accessing mental health
services within the African American community.37 Therefore, although there is no appropriate
comparison for this study, we conclude that depression is prevalent among older African
American cancer patients.
Several demographic factors in African American cancer patients were found to be highly
associated with a high depression score. In concurrence with other studies, we found that
younger-aged (<65 years) cancer patients were more at risk of depression than were older
patients.14,16,18 Several explanations have been proposed for this age-related trend. A cancer
diagnosis may have a more devastating effect on younger patients because they are less likely
to expect the experience of chronic illness. There is also the possibility of thoughts of unfinished
goals associated with the threat of an early death.14 Cancer may also affect the daily lifestyles
of younger patients because of job concerns and the devastation on their families.14,16 Younger
patients are known to have more cancer-related thoughts such as the cause of cancer and “Why
me?”38 These types of thoughts can lead to a poorer psychological adjustment for cancer
patients and increase the anxiety and depression experienced by them. In addition, it is possible
that differences in cancer pathologies that occur among adults of different ages may predispose
younger cancer patients to a greater risk of depression than older cancer patients. For example,
in a review of age differences in psychosocial effects of breast cancer, younger premenopausal
women were found to have more aggressive cancers and a higher rate of recurrence than
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postmenopausal women.39,40 In addition, younger women received stronger treatments and
reported a greater number of adverse effects to treatment.39,40 Another explanation for the
effect of age on depression is methodological: younger patients may have received their cancer
diagnosis more recently than older patients and have had less time to adjust to the disease at
the time of data collection.41 Although methodological issues may contribute to the observed
age trend in depression among cancer patients, there still exists a significant association, and
efforts must be made to identify depression in younger cancer patients.
The economic and social impacts of not being able to hold a job can have serious psychological
effects. Consistent with other studies, we found that African American cancer patients who
lost their jobs because of their health had more than 3 times greater risk of depression than
patients who were employed at the time of the study. Studies have found that job loss and the
inability to work cause higher rates of emotional distress and depression in cancer patients.
41,42 Because of symptoms and adverse effects related to cancer disease and treatment such as
pain and fatigue, many patients are unable to continue working because of absenteeism and
the time needed for treatment.42 Job loss can impact the daily routine, relationships with friends
and family, and financial status.43 Therefore, it is particularly distressing for patients who have
been the breadwinner of the home because they have to cope with the disruption of their
identity.43
An association was also observed between lack of health insurance and depression among these
older African American cancer patients. Although lack of insurance was not significantly
associated with depression after controlling for other variables such as employment status, lack
of insurance plays an important role in the onset of depression in cancer patients. Lack of
insurance typically closes doors for healthcare, mental or otherwise, and can cause exceptional
burden on cancer patients who are receiving treatment. Anxiety over where to get healthcare
and how to pay for it can result in depression for these patients.
Living in proximity to family can be a protective factor from depression for cancer patients.
Families including spouses are said to provide 85% of the social support received by cancer
patients.44 Although recent research has not yet explored the relationship between proximity
to family and depression among cancer patients, we can infer from literature that unmarried
patients and patients without large social networks are more likely to be depressed.44–46 We
found that 39% of our sample lived alone. Using living alone as an indicator for proximity to
family, we found that those who lived alone had 2 times greater chance of having depressive
symptoms than those patients who lived with someone. Not having someone at home to care
and support the cancer patient can increase the worries and anxiety that the patient experiences.
In elderly patients, it can also increase the burden of daily living. It is interesting to note,
however, that no association was found between marital status and depression.
The only illness-related factor that was found to be significantly associated with depression
was having symptoms from cancer. Many previous studies have also noted that having physical
symptoms of cancer is strongly associated with depression in cancer patients.6,12,18,47,48
However, these studies are also focused on a primarily well-educated, middle-class white
sample, much unlike our sample of relatively low-income African American sample. Although
we do not have data on the specific symptoms experienced by older African American cancer
patients in this study, we found that merely the presence of any symptom led to a 2.62 greater
odds of depression. The most prevalent symptoms that are associated with depression are
fatigue, pain, and insomnia.48 Experiencing symptoms brings the disease to the forefront of
the patients’ minds as it impacts behaviors, cognition, and relationships.49
This study has several limitations. One weak point in the study is the cross-sectional study
design that limits the analysis to only 1 snapshot of depression in the patients. Because
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depression is known to be variable over time, to assess the complexities associated with
depression, longitudinal studies are greatly needed. Another limitation was that depression was
measured by a self-report survey and not assessed by a trained professional. However, because
depression is so often under-diagnosed particularly in the African American population, the
survey was the best option available to get a preliminary assessment of depression in the
patients. Moreover, many studies use a self-report survey because of the occurrence of mis-
diagnosis of depression. Another limitation in this study is the lack of comparability with other
studies examining depression among other demographically similar cancer patients. This study
is the first to examine the risk factors of depression in older African American cancer patients
and will serve as a reference point for future studies exploring this understudied population.
Conclusions
There is a need for further research examining depression in African American cancer patients.
The current study shows that African American cancer patients who are younger-aged (<65
years), lost their jobs because of health concerns, live alone, and have at least 1 symptom related
to cancer are at greater risk of depression. More research needs to be done to substantiate these
findings and to better inform intervention studies aimed at improving the psychosocial
functioning of African American cancer patients. Future studies designed to validate our
findings in African Americans in different socioeconomic groups as well as from other
geographic regions will help in identifying common factors that predispose African American
cancer patients to depression. In addition, longitudinal studies examining the factors associated
with developing depression during the cancer trajectory will be useful in identifying patients
at risk at early stages and possibly prevent the comorbidities and burden associated with
depression.
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Table 1
Demographic and Clinical Factors of 283 African American Cancer Survivors by Geriatric Depression Scale
(GDS) Scores
No. Cases (%)
Total Sample GDS <5 GDS ≥5
Characteristics N = 283 n = 206 n = 77 Pa
Demographic factors
 Age, y <.01a
  50–59 108 (38.3) 65 (31.7) 43 (55.8)
  60–64 68 (24.1) 49 (23.9) 19 (24.7)
  ≥65 106 (37.6) 91 (44.4) 15 (19.5)
 Sex .78
  Men 114 (40.3) 84 (40.8) 30 (39.0)
  Women 169 (59.7) 122 (59.2) 47 (61.0)
 Education .57
  High school graduate 162 (57.2) 120 (58.3) 42 (54.6)
  Not high school graduate 121 (42.8) 86 (41.7) 35 (45.5)
 Marital status .47
  Married 57 (20.1) 40 (19.4) 17 (22.1)
  Widowed 67 (23.7) 53 (25.7) 14 (18.2)
  Divorced 81 (28.6) 60 (29.1) 21 (27.3)
  Never married 78 (27.6) 53 (25.7) 25 (32.5)
 Employment status <.01
  Employed 23 (8.1) 19 (9.2) 4 (5.2)
  Retired 97 (34.3) 82 (39.8) 15 (19.5)
  Lost job due to health 129 (45.6) 81 (39.3) 48 (62.3)
  Not employed 34 (12.0) 24 (11.7) 10 (13.0)
 Yearly income .93a
  0–4,999 67 (24.5) 47 (23.6) 20 (27.0)
  5,000–9,999 96 (35.2) 73 (36.7) 23 (31.1)
  10,000–19,999 77 (28.2) 55 (27.6) 22 (29.7)
  >20,000 33 (12.1) 24 (12.1) 9 (12.2)
 Insurance status .02
  Have insurance 201 (71.0) 154 (74.8) 47 (61.0)
  No insurance 82 (29.0) 52 (25.2) 30 (39.0)
 Live alone .02
  Yes 93 (32.9) 76 (36.9) 17 (22.1)
  No 190 (67.1) 130 (63.1) 60 (77.9)
Illness-related factors
 Time since cancer diagnosis, y .87a
  0–3 217 (77.2) 156 (76.5) 61 (79.2)
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No. Cases (%)
Total Sample GDS <5 GDS ≥5
Characteristics N = 283 n = 206 n = 77 Pa
  3–5 19 (6.8) 16 (7.8) 3 (3.9)
  >5 45 (16.0) 32 (15.7) 13 (16.9)
 Type of cancer .78
  Breast 84 (29.7) 66 (32.0) 18 (23.4)
  Lung 61 (21.6) 43 (20.9) 18 (23.4)
  Prostate 20 (7.1) 15 (7.3) 5 (6.5)
  Colon 35 (12.4) 24 (11.7) 11 (14.3)
  Head and neck 22 (7.8) 16 (7.8) 6 (7.8)
  Other 61 (21.6) 42 (20.4) 19 (24.7)
 Tumor stageb .65
  0–2 84 (46.4) 58 (45.3) 26 (49.1)
  3–4 97 (53.6) 70 (54.7) 27 (50.9)
 Diagnosis stateb .23
  Newly diagnosed/1st remission 128 (73.1) 89 (70.6) 39 (79.6)
  2nd Primary lesion/metastases 47 (26.9) 37 (29.4) 10 (20.4)
 Symptoms due to cancer/treatmentb <.0001
  Symptomatic 97 (54.2) 58 (45.0) 39 (78.0)
  Asymptomatic 82 (45.8) 71 (55.0) 11 (22.0)
a
P values with asterisks based on Cochran-Armitage trend test; other P values from Pearson χ2 test.
b
Varied sample sizes because of missing responses: tumor stage, n = 181; diagnosis state, n = 175; symptoms, n = 179.
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Table 2
Multivariate Logistic Regression Predicting Depression Among 283 Older African American Cancer Patients
Variables n Crude OR (95% CI) Adjusted OR (95% CI)
Age, y
 50–59 108 4.06 (2.08–7.91) 2.96 (1.35–6.49)
 60–64 68 2.38 (1.11–5.09) 1.71 (0.72–4.04)
 ≥65 106 1.00 1.00
Employment status
 Not employed 34 1.98 (0.54–7.31) 2.45 (0.62–9.72)
 Retired 97 0.87 (0.26–2.92) 1.57 (0.44–5.67)
 Lost job due to health 129 2.82 (0.90–8.76) 3.30 (1.00–10.84)
 Employed 23 1.00 1.00
Insurance status
 No insurance 82 1.89 (1.09–3.30) 1.35 (0.72–2.54)
 Have insurance 201 1.00 1.00
Live alone
 Yes 93 2.06 (1.12–3.79) 2.21 (1.14–4.27)
 No 190 1.00 1.00
Symptoms due to cancer/treatment
 Symptomatic 97 2.62 (1.53–4.50) 2.69 (1.50–4.84)
 Asymptomatic 82 1.00 1.00
Abbreviations: CI, confidence interval; OR, odds ratio.
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